Results 81 to 90 of about 200,279 (211)

Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS)

Diabetology & Metabolic Syndrome
Background Metabolic syndrome (MetS) is a cluster of risk factors related to diabetes and cardiovascular disease (CVD). Given that early identification of MetS might decrease CVD risk, it is imperative to establish a simple and cost-effective method to ...
Hossein Babaahmadi‐Rezaei, Maedeh Raeisizadeh, Vahid Zarezade, Kourosh Noemani, Ahmad Mashkournia, Hossein Ghaderi-Zefrehi   +5 more
doaj   +1 more source

HYPERLIPIDEMIA IN ACUTE PANCREATITIS: CONCOMITANT DISORDER OR A CAUSE? [PDF]

, 2014
Acute pancreatitis is a common condition with alcohol and gallstones being the most frequent etiologies. The aim of our study was to determine the prevalence of hyperlipidemia, its etiopathogenetic role and influence on outcomes in patients with acute ...
Stanojevic, Goran, Damnjanovic, Zoran, Radojkovic, Danijela Branislav, Jeremic, Ljiljana Miroslav, Stevanovic, Goran, Radojković, Milan Dragoslav, Stojanovic, Miroslav Petko   +6 more
core  

Association of urinary bisphenol A with hyperlipidemia and all-cause mortality: NHANES 2003-2016.

PLoS ONE
BackgroundThe connection between urinary bisphenol A (BPA) and hyperlipidemia is still unclear, and few studies have evaluated whether urinary BPA affects mortality among individuals with hyperlipidemia.
Lijuan Guo, Pin Zhao, Shilong Xue, Zhaowei Zhu   +3 more
doaj   +1 more source

Cluster Headache Associated with Primary Hyperlipidemia (Annotations)

Study of cluster headaches as associated with primary hyperlipidemia, study of two brothers suffering from cluster headache of the chronic variant as well as hyperlipidemia.
Irene E. Loewenfeld, PhD (1921-2009)
core  

Hyperlipidemia: Should Primary Care Providers Treat More Than LDL? [PDF]

, 2006
Purpose: To provide an overview of current recommendations for the treatment of hyperlipidemia and discuss the need for treatment of all aspects of lipids. Data Sources: Selected clinical research articles and NCEP guidelines. Conclusions: Evidence-based
Masterman, Christy B.
core   +2 more sources

qPCR validation for selected genes affected by hyperlipidemia.

, 2013
qPCR validation for selected genes affected by hyperlipidemia.
Lang Lei (447100), Yin Xiao (447102), Houxuan Li (447101), Fuhua Yan (281312)   +3 more
core   +1 more source

Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia

, 2012
[[abstract]]"Uremic patients with hyperlipidemia are classified at high atherogenic risk due to oxidative stress induced by regular hemodialysis process (hemoincompatibility) and a high level of oxidized low-density lipoprotein (ox-LDL).
;Chen, Tung-Sheng;Liou, Show-Yih;Wu, Hsi-Chin;Tsai, Fuu-Jen;Tsai, Chang-Hai;黃志揚;HUANG, CHIH-YANG;Chang, Yen-Lin
core  

PDE5 inhibition mitigates heart failure in hyperlipidemia

PDE5 inhibitors was reported to play a protective role in both regulating lipid metabolism and reducing heart failure (HF). This study aimed to clarify the effectiveness of PDE5 inhibitors against hyperlipidemia-related HF by combining evidence from ...
Chen, Keyuan, Huang, Wuqing,, Chen, Liangwan,, Zhang, Naiqi,, Qiu, Zhihuang,, Xiao, Jun,, Huang, Wuqing, Yang, Xi,, Qiu, Zhihuang, Chen, Liangwan, Xiao, Jun, Chen, Keyuan,, Zhang, Naiqi, Gao, Ziting,, Ji, Jianguang,, Yang, Xi, Gao, Ziting, Lund University., You, Sujun, Ji, Jianguang, You, Sujun,   +20 more
core   +1 more source

Drugs for the Treatment of Hyperlipidemia

, 2001
Hyperlipidemia is a major risk factor for the development of cardiovascular disease. Considerable evidence suggests that drugs with the ability to lower low density lipoprotein-cholesterol also lower cardiovascular deaths.
Stone, William L., Chin, T K.
core   +1 more source

Treatment of Hyperlipidemia

, 2017
The Hyperlipidemia is a medical disorder, which is also known as Hypercholesterolemia or Hyperlipoproteinemia. The term hyperlipidemia refers to condition of abnormal excess of fatty substances.
Barghi Kashani, Marjan
core